Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes.
null nullDavid M NathanJohn M LachinAshok BalasubramanyamHenry B BurchJohn B BuseNicole M ButeraRobert M CohenJill P CrandallSteven E KahnHeidi Krause-SteinraufMary E LarkinNeda RasouliMargaret TiktinDeborah J WexlerNaji YounesPublished in: The New England journal of medicine (2022)
All four medications, when added to metformin, decreased glycated hemoglobin levels. However, glargine and liraglutide were significantly, albeit modestly, more effective in achieving and maintaining target glycated hemoglobin levels. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; GRADE ClinicalTrials.gov number, NCT01794143.).